![Peter Bisgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Bisgaard
Président chez
Engrail Therapeutics, Inc.
Profil
Peter Tuxen Bisgaard is currently the Chairman at Oncxerna Therapeutics, Inc. and Engrail Therapeutics, Inc. He is also the Managing Director at Novo Ventures 1 A, the Director at The Outpost Ltd., and the Managing Director at Nan Fung Life Sciences.
Additionally, he is the Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
In his former positions, Mr. Bisgaard served as the Chairman at HTG Molecular Diagnostics, Inc. from 2015 to 2017.
He was also the Chairman at Neurokey A and Otonomy, Inc. from 2013 to 2015.
Furthermore, he held the role of Independent Director at Ra Pharmaceuticals, Inc. from 2015 to 2019.
He has also served as an Independent Non-Executive Director at Eargo, Inc. from 2017 to 2022.
Additionally, he held various director positions at Light Sciences Oncology, Inc., Asante Solutions, Inc., Thesan Pharmaceuticals, Inc., Azanta Danmark A, Lundbeck Seattle BioPharmaceuticals, Inc., Nevro Corp., Hemofocus ApS, Altheos, Inc., Ceterix Orthopaedics, Inc., Bolt Biotherapeutics, Inc., Entasis Therapeutics, Inc., Chromaderm, Inc., Outpost Medicine, Inc., and Inozyme Pharma, Inc. He was also a Principal at McKinsey & Co., Inc. and a Senior Partner at Novo Holdings AS (Denmark) from 2009 to 2017.
Mr. Bisgaard obtained his graduate degree from the Technical University of Denmark in 1998.
Postes actifs de Peter Bisgaard
| Sociétés | Poste | Début |
|---|---|---|
The Outpost Ltd.
 The Outpost Ltd. Marine ShippingTransportation The Outpost Ltd. is an American multifaceted company specializing in helping technology startups and scaleups access, win, and scale federal government contracts, particularly in the defense, energy, and data sectors. The company is based in Hico. The company provides government go-to-market services such as strategy design, proposal writing, compliance, and customer validation, allowing clients to focus on product development while navigating procurement processes. The Outpost leverages expertise from former federal innovation leaders and proprietary AI tools to optimize contract strategies across all growth stages. In addition to contract facilitation, The Outpost operates Outpost Ventures, an investment arm that backs dual-use companies developing technologies aligned with national security and commercial scalability, investing in areas like energy infrastructure, digital infrastructure, defense systems, and applied AI. The company also partners with government teams to design and execute federal innovation programs, offering services such as innovation project management, technology scouting, needs assessments, training, and accelerated technology deployment. | Directeur/Membre du Conseil | - |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Private Equity Investor | 01/09/2017 |
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases | Président | - |
Oncxerna Therapeutics, Inc.
 Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Président | - |
Nan Fung Life Sciences
 Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Peter Bisgaard
| Sociétés | Poste | Fin |
|---|---|---|
| EARGO, INC. | Directeur/Membre du Conseil | 03/08/2022 |
| RA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/06/2019 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Président | 07/03/2017 |
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01/01/2017 |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Peter Bisgaard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
28
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 28 |
|---|---|
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Light Sciences Oncology, Inc.
 Light Sciences Oncology, Inc. Pharmaceuticals: MajorHealth Technology Provides light infusion therapy systems | Health Technology |
Asante Solutions, Inc.
 Asante Solutions, Inc. Medical SpecialtiesHealth Technology Develops insulin delivery devices | Health Technology |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces novel therapeutics for skin disorders | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta Danmark A/S
 Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Nevro Corp.
 Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Finance |
Neurokey A/S
 Neurokey A/S Pharmaceuticals: MajorHealth Technology Develops drugs for the critical care field | Health Technology |
Hemofocus ApS
 Hemofocus ApS Medical SpecialtiesHealth Technology Provides anticoagulant products | Health Technology |
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurology diseases | Health Technology |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Ceterix Orthopaedics, Inc.
 Ceterix Orthopaedics, Inc. Medical SpecialtiesHealth Technology Develops novel surgical tools for arthroscopic procedures | Health Technology |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Eargo, Inc.
 Eargo, Inc. Medical SpecialtiesHealth Technology Designs and manufactures hearing aids | Health Technology |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Chromaderm, Inc.
 Chromaderm, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotech company which develops topical PKC-beta inhibitor | Health Technology |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
The Outpost Ltd.
The Outpost Ltd. Marine ShippingTransportation The Outpost Ltd. is an American multifaceted company specializing in helping technology startups and scaleups access, win, and scale federal government contracts, particularly in the defense, energy, and data sectors. The company is based in Hico. The company provides government go-to-market services such as strategy design, proposal writing, compliance, and customer validation, allowing clients to focus on product development while navigating procurement processes. The Outpost leverages expertise from former federal innovation leaders and proprietary AI tools to optimize contract strategies across all growth stages. In addition to contract facilitation, The Outpost operates Outpost Ventures, an investment arm that backs dual-use companies developing technologies aligned with national security and commercial scalability, investing in areas like energy infrastructure, digital infrastructure, defense systems, and applied AI. The company also partners with government teams to design and execute federal innovation programs, offering services such as innovation project management, technology scouting, needs assessments, training, and accelerated technology deployment. | Transportation |
Inozyme Pharma, Inc.
 Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
Nan Fung Life Sciences
Nan Fung Life Sciences Investment ManagersFinance Nan Fung Life Sciences invests in companies located across the globe. The firm focuses on life sciences sectors such as health technology, biotechnology, pharmaceuticals, electrical instruments and medical services. It provides financing for seed, early and growth stage capital requirements. | Finance |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for treating neuron diseases | Health Technology |
